Procedure for Remote Inspection as a Part of Compliance Inspection on Drugs and Regenerative Medical Products
Information
Type
Notification
Regulated products
Regenerative Medical Products
Last updated
May 25, 2022
Description
PMDA/CPE Notification No. 0525001
Tags
Organization
Country / Region
Japan
License
Other (Public Domain)